In Successful Cancer Trial, Therapy "Dissolves" Stage IV Tumor in 3 Weeks

 
Related

How to celebrate Valentine's Day After Marriage

Good News
262 points

Getting Married Is Not an Accomplishment

Good News
762 points



Most recent

These popular breakfast cereals have more sugar than a scoop of ice cream

Crazy stuff
152 points

Proyecto artístico controvertido que ilustra las dificultades de Roma

ECiberpasquinero Salazar Herrera
144 points

Descubren efectos benéficos de la metformina en la cicatrización

ECiberpasquinero Salazar Herrera
370 points

How I quit coffee for 30 days

Luffy News
112 points

Eat one egg every day - you'll be surprised what happens to your body

Luffy News
54 points

Terapia blanco molecular contra el cáncer

ECiberpasquinero Salazar Herrera
472 points

Horrible! Mom found something disgusting in her KFC meal

Crazy stuff
100 points

These food habits will give you extra energy and make you more productive

About everything
40 points

This Husky puppy was found with his mouth tied and his legs broken

Animals
244 points

7 hidden dangers of marijuana that young people today don t know

About everything
22 points
SHARE
TWEET
An experimental drug combination dissolved a cancerous tumor so fast, it caught researchers completely off-guard. The two-drug combo completely eliminated a woman’s melanoma — and left her completely cancer-free — in just three weeks.

In Successful Cancer Trial, Therapy "Dissolves" Stage IV Tumor in 3 Weeks

Researchers were surprised at how well the drug combination worked, shrinking tumors at least 80% in more than half of the 142 patients in the trial. And the combination completely eradicated tumors in 22% of patients.

In the rapid recovery case, a 49-year-old woman was given the drugs to treat a large tumor on her chest. Doctors continued to monitor her after the treatment and she remains cancer-free. (The image on the left shows the cancer mass with an asterisk* and the photo on the right is magnified)

“I was astonished; I’d never seen anything like that,” Dr. Paul Chapman, head of the melanoma section at the Memorial Sloan Kettering Cancer Center in New York told Live Science. “She said the tumor had just kind of dissolved.”

Chapman was lead author of the research report published in the New England Journal of Medicine about the trial, part of research needed for the FDA to approve combined use of the drugs.

The woman, and others in the trial, were treated with a process called immunotherapy — using drugs to boost a person’s own immune system to fight cancer. It’s a relatively new approach to treating deadly melanoma.

he patients were given two FDA-approved melonoma drugs already being used to treat the cancer, but not used in combination before — ipilimumab (sold under the brand name Yervoy) and nivolumab (brand name Opdivo).

Ipilimumab allows the body to override part of the immune system, turning loose waves of immune cells to kill cancer cells. Nivolumab strengthens certain immune cells, called “T cells,” preventing them from dying and allowing them to continue attacking cancer longer.

Chapman says the tests confirm a suspicion doctors and researchers have had for a long time that the immune system can fight cancer. This research may open new doors in unleashing that potential.

Fuente: www.goodnewsnetwork.org
SHARE
TWEET
To comment you must log in with your account or sign up!
Featured content